A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction

A peptide vaccine targeting angiotensin II (Ang II) was recently developed as a novel treatment for hypertension to resolve the problem of noncompliance with pharmacotherapy. Ang II plays a crucial role in the pathogenesis of cardiac remodeling after myocardial infarction (MI), which causes heart fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Ryo, Suzuki, Jun-ichi, Wakayama, Kouji, Maejima, Yasuhiro, Shimamura, Munehisa, Koriyama, Hiroshi, Nakagami, Hironori, Kumagai, Hidetoshi, Ikeda, Yuichi, Akazawa, Hiroshi, Morishita, Ryuichi, Komuro, Issei, Isobe, Mitsuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339733/
https://www.ncbi.nlm.nih.gov/pubmed/28266578
http://dx.doi.org/10.1038/srep43920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339733/
https://www.ncbi.nlm.nih.gov/pubmed/28266578
http://dx.doi.org/10.1038/srep43920

Ejemplares similares